Article Text

Download PDFPDF
Original research
Cognitive improvement following endovascular embolization in patients with intracranial dural arteriovenous fistula: The Neuropsychology in dural ArterIal Fistula (NAIF) Study
  1. Laura Ludovica Gramegna1,2,
  2. Gemma Ortega3,
  3. Lavinia Dinia4,
  4. Sonia Aixut5,
  5. Santiago Rosati6,
  6. Pedro Vega7,
  7. Alex Lüttich8,
  8. Sebastian Remollo9,
  9. Alejandro González10,
  10. Eduardo Murias7,
  11. Oscar Chirife Chaparro5,
  12. Manuel Moreu11,
  13. Manuel Requena1,12,
  14. Marta de Dios Lascuevas12,
  15. David Hernandez12,
  16. Manuel Quintana13,
  17. Josep Puig14,
  18. Alex Rovira15,
  19. Alejandro Tomasello1,12
  1. 1 Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
  2. 2 Servicio de Radiología, Unidad de Neurorradiología, Hospital del Mar, Barcelona, Spain
  3. 3 Universitat Internacional de Catalunya, Research Center and Memory clinic Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain
  4. 4 Department of Radiology, Hospital de la Santa Creu i Sant Pau, Interventional Neuroradiology Section, Barcelona, Spain
  5. 5 Department of Neuroradiology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain
  6. 6 Department of Radiology, Clinical San Carlos Hospital, Interventional Neuroradiology Unit, Madrid, Spain
  7. 7 Department of Radiology, Hospital Universitario Central de Asturias, Interventional Neuroradiology, Oviedo, Spain
  8. 8 Department of Radiology, Donostia University Hospital, Interventional Neuroradiology Section, Donostia-San Sebastián, Spain
  9. 9 Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Interventional Neuroradiology Unit, Badalona, Spain
  10. 10 Department of Radiology, Hospital Universitario Virgen del Rocío, Interventional Neuroradiology, Seville, Spain
  11. 11 Department of Radiology, Hospital Clínico Universitario San Carlos, Interventional Neuroradiology Unit, Madrid, Spain
  12. 12 Interventional Neuroradiology Section, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
  13. 13 Department of Neurology, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Epilepsy Unit, Barcelona, Spain
  14. 14 Radiology Department CDI, Hospital Clinic of Barcelona, Barcelona, Spain
  15. 15 Department of Radiology, Neuroradiology Section, Vall d'Hebron University Hospital, Barcelona, Spain
  1. Correspondence to Dr Laura Ludovica Gramegna; lauraludovica.gramegna{at}gmail.com

Abstract

Background Cognitive improvement after endovascular embolization of an intracranial dural arteriovenous fistula (dAVF) remains unexplored. We aim to investigate cognitive changes following endovascular embolization of dAVFs.

Methods Neuropsychology in dural ArterIal Fistula (NAIF) was a prospective multicentric study including patients with an angiographic diagnosis of dAVF who underwent endovascular embolization over the course of 4 years. A complete neuropsychological evaluation comprising five cognitive domains (attention and executive functions, memory, language, praxis, gnosis) was performed at baseline and 3 months follow-up. Mean Z scores for cognitive tests were compared pre- and post-treatment using paired sample t-tests, where higher Z scores indicate better cognition. Effect sizes were computed as Cohen’s d.

Results A total of 32 patients (mean age 61.1±15.4 years, 10 (31.3%) females) were included. Patients exhibited improved performance in attention and executive functions: executive functions–attention (+0.282, P=0.009, d=0.29), executive functions–fluencies (+0.283, P=0.029, d=0.4), and executive functions–processing speed (+0.471, P=0.039, d=0.41). There was an increase in memory: verbal learning and verbal delayed recall scores (+0.513, P<0.001, d=0.55, and +0.385, P=0.001, d=0.41, respectively), while verbal recognition parameters (+0.839, P=0.086, d=0.37) and visual memory (delayed recall) (+0.430, P=0.060, d=0.35) displayed trends toward improved performance. Regarding language, there was significant overall improvement (+0.300, P=0.014, d=0.24), but neither praxis nor gnosis changed significantly. These cognitive outcomes were independent of the severity (measured as Cognard classification), and no patient experienced cognitive worsening.

Conclusion This study suggests that endovascular embolization confers cognitive benefits on dAVF patients undergoing endovascular embolization and may be beneficial even for patients with a low risk of hemorrhage.

  • fistula
  • arteriovenous malformation
  • vascular malformation
  • liquid embolic material
  • embolic

Data availability statement

Data are available upon reasonable request.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request.

View Full Text

Footnotes

  • X @pedrovegavaldes, @Sremollo, @oscarsabino, @neuroplumber

  • Contributors LLG: concept, data analysis, drafting, and revising the manuscript and guarantor. GO: concept, data analysis, drafting, and revising the manuscript. LD, SA, SR, PV, AL, SR, AG, EM, OC, MM, MR, MdD, DH: data collection and analysis. MQ: concept, data analysis, drafting, and revising the manuscript. JP: data collection and analysis, drafting and revising the manuscript. AR: concept, data analysis, drafting, and revising the manuscript. AT: concept, data acquisition, and analysis, drafting and revising the manuscript.

  • Funding This study was supported by Medtronic. The supporter had no role in the design, conduct, collection, management, analysis, and interpretation of the data, preparation and approval of the manuscript

  • Competing interests This study was supported by Medtronic. The supporter had no role in the design, conduct, collection, management, analysis, and interpretation of the data, preparation and approval of the manuscript. Dr Gramegna had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr Tomasello has received personal fees from Anaconda Biomed, Balt, Medtronic, Perflow, and Stryker outside the submitted work. No other disclosures were reported.

  • Provenance and peer review Not commissioned; externally peer reviewed.